Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Psychedelic/Assisted Therapies

Recent news which mentions Psychedelic/Assisted Therapies

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Psychoanalysis Meets LSD: Argentina's Lost 1950s Era Of Psychedelic Therapy
Tickers NEWS
Tags News Alberto Fontana Mescaline
From Benzinga
Psychedelics And Mental Health: FDA Stalls, But States Forge Ahead
Tickers MDMA NEWS
Tags Market News Cannabis the hill
From Benzinga
How Strategic Real Estate Investments Are Driving Psychedelic Therapy's Growth, Bridging Gaps In Mental Healthcare
Tickers IIPR MDMA
Tags Healing Realty Trust Cody Shandraw Markets
From Benzinga
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Tickers AWKNF BETRF CMND FLHLF
Tags FLHLF BETRF PBM
From Benzinga
Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
Tickers NEWS NUMIF
Tags Psychedelics Psychedelics Research Biotech
From Benzinga
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
Tickers NEWS OPTHF
Tags Psychedelics Research Legal Management
From Benzinga
Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More
Tags Benzinga FDA Global
From Benzinga
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Tickers CMND CMPS CYBN FLHLF
Tags Benzinga Psychedelic/Assisted Therapies Cannabis
From Benzinga
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
Tickers ATAI CMPS
Tags Psychedelics Biotech Psychedelic/Assisted Therapies
From Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
Tickers ATAI NEWS
Tags Biotech 5/MeO/DMT Psychedelics
From Benzinga
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
Tickers MNMD NEWS
Tags Legal Management MNMD
From Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Tickers ATAI CMND CMPS CYBN
Tags CMPS Psychedelics Research CYBN
From Benzinga
Psychedelics Update: Task Forces In Three States, Decrim No-Go, Arizona Psilocybin Centers, Utah And More
Tags Psychedelics Reform Psychedelics Legal
From Benzinga
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Tickers ATAI BETRF CMND ENVB
Tags OPTHF Biotech CMND
From Benzinga
Fed Agency Grants $14M To Gilgamesh For Cardiac-Safe Ibogaine Analog Targeting Opioid Use Disorder
Tickers NEWS
Tags News Legal Management
From Benzinga
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
Tickers CMPS CYBN MNMD
Tags CYBN CMPS Legal
From Benzinga
Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia
Tickers PBM
Tags PBM Psyence Group Inc/ Legal
From Benzinga
MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds
Tickers MNMD NEWS
Tags News MNMD Management
From Benzinga
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
Tickers CMPS MNMD NEWS
Tags CMPS Legal MNMD
From Benzinga
Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More
Tickers BWVI CMPS IBOGF
Tags Cannabis Financing Rock Feilding/Mellen
From Benzinga
Psychedelics Reform Update: Connecticut's Decriminalization, Vermont Hearings, Arizona's Psilocybin Services & More
Tags Legal Psychedelics Management
From Benzinga
Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
Tickers BRAXF FLHLF OPTHF SILFF
Tags Legal BRAXF Management
From Benzinga
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
Tickers GHRS NEWS
Tags Financing Cannabis Market News
From Benzinga
Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment
Tickers CMPS
Tags Market News Cannabis Financing
From Benzinga
Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'
Tickers BRAXF BWVI CMPS NEWS
Tags CMPS Benzinga Psychedelics Podcast BRAXF
From Benzinga
Beckley Academy's Open-Source Psychedelic Therapy Learning Framework Is Out: What's It All About? Authoring Team Shares Insights
Tags Psychedelics Research Health Care Psychedelics
From Benzinga
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
Tickers MNMD
Tags MNMD Management 2023 financial results
From Benzinga
LSD Microdosing For Depression? This Clinical Study Reveals Promising Results
Tickers NEWS
Tags Psychedelic/Assisted Therapies Benzinga At/Home Therapy
From Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Tickers ATAI AWKNF CMND CYBN
Tags FLHLF Psychedelic Research Legal
From Benzinga
Medford Massachusets Move To Decriminalize Psychedelics Has Statewide Reform Implications
Tags Psychedelics Reform Management Psychedelics
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.